Plain-English translation of NCT07086924 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Psoriasis research guide โThis study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
Researchers want to understand why โ a common medication used to treat moderate to severe psoriasis and psoriatic arthritis โ works well for some people but not others. This study will look at a specific genetic variation that may influence how your body responds to this medication. By studying this gene in people with these conditions, doctors hope to eventually predict who will benefit most from the treatment.
Currently, doctors prescribe this medication to many patients, but some respond very well while others don't see much improvement. If researchers can identify the genetic factors that predict good response, doctors could personalize treatment plans and help patients avoid unnecessary side effects or delays in finding the right therapy.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this study, you will have a blood sample taken so researchers can analyze your genetic variation. You will be placed into one of three groups: people with psoriasis, people with psoriatic arthritis, or a healthy control group. You will need to attend scheduled follow-up visits to allow researchers to track how well the medication is working for you and monitor for any side effects. The study will help doctors understand the link between your genes and your response to treatment.
AI-generated summary from trial data ยท Jun 11, 2026 ยท Not medical advice
Egypt